These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 35642766)
1. Editorial Comment: Prolonged Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy Necessitates a Long Imaging Follow-Up Interval. Perry H AJR Am J Roentgenol; 2022 Oct; 219(4):567. PubMed ID: 35642766 [No Abstract] [Full Text] [Related]
2. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors. Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774 [No Abstract] [Full Text] [Related]
3. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors. Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425 [No Abstract] [Full Text] [Related]
4. Follow-up of COVID-19 Vaccine-related Axillary Lymphadenopathy before 12 Weeks Is Unnecessary. Moy L; Kim E Radiology; 2022 Oct; 305(1):54-55. PubMed ID: 35471114 [No Abstract] [Full Text] [Related]
5. Management of Unilateral Axillary Lymphadenopathy Detected on Breast MRI in the Era of COVID-19 Vaccination. Edmonds CE; Zuckerman SP; Conant EF AJR Am J Roentgenol; 2021 Oct; 217(4):831-834. PubMed ID: 33543649 [TBL] [Abstract][Full Text] [Related]
6. COVID-19 Vaccination-Associated Axillary Adenopathy: Imaging Findings and Follow-Up Recommendations in 23 Women. Mortazavi S AJR Am J Roentgenol; 2021 Oct; 217(4):857-858. PubMed ID: 33624520 [TBL] [Abstract][Full Text] [Related]
7. The Canadian Society of Breast Imaging Recommendations for the Management of Axillary Adenopathy in Patients with Recent COVID-19 Vaccination - Update. Seely JM; Barry MH Can Assoc Radiol J; 2021 Nov; 72(4):601-602. PubMed ID: 33622040 [No Abstract] [Full Text] [Related]
8. Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients. Özütemiz C; Krystosek LA; Church AL; Chauhan A; Ellermann JM; Domingo-Musibay E; Steinberger D Radiology; 2021 Jul; 300(1):E296-E300. PubMed ID: 33625300 [TBL] [Abstract][Full Text] [Related]
9. Editorial Comment: Duration of Axillary Lymphadenopathy After COVID-19 Vaccine Booster Administration. Mullen LA AJR Am J Roentgenol; 2023 Aug; 221(2):183. PubMed ID: 36946901 [No Abstract] [Full Text] [Related]
10. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study. Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985 [TBL] [Abstract][Full Text] [Related]
11. Frequency and Characteristics of Nodal and Deltoid FDG and Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000 [No Abstract] [Full Text] [Related]
12. COVID-19 Vaccination and Subclinical Axillary Lymphadenopathy on Mammogram: Correspondence. Mungmunpuntipantip R; Wiwanitkit V Acad Radiol; 2022 Apr; 29(4):633. PubMed ID: 35058134 [No Abstract] [Full Text] [Related]
13. COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings. Nguyen DL; Ambinder EB; Myers KS; Mullen LA; Panigrahi B; Oluyemi E AJR Am J Roentgenol; 2022 Jun; 218(6):997-998. PubMed ID: 34935404 [TBL] [Abstract][Full Text] [Related]
14. Axillary Adenopathy after COVID-19 Vaccine: No Reason to Delay Screening Mammogram. Wolfson S; Kim E; Plaunova A; Bukhman R; Sarmiento RD; Samreen N; Awal D; Sheth MM; Toth HB; Moy L; Reig B Radiology; 2022 May; 303(2):297-299. PubMed ID: 35133198 [No Abstract] [Full Text] [Related]
15. Reply to comment to "axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women". Marcon M; Catanese C; Scarano AL; Del Grande F; Manganiello M; Palermo M; Rizzo S Radiol Med; 2023 Dec; 128(12):1595-1596. PubMed ID: 37907674 [No Abstract] [Full Text] [Related]
16. Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination. Robinson KA; Maimone S; Gococo-Benore DA; Li Z; Advani PP; Chumsri S JAMA Oncol; 2021 Sep; 7(9):1395-1397. PubMed ID: 34292295 [TBL] [Abstract][Full Text] [Related]
17. Supraclavicular lymphadenopathy after COVID-19 vaccination in Korea: serial follow-up using ultrasonography. Kim B; Park Y; Kim EK; Lee SH Clin Imaging; 2021 Nov; 79():201-203. PubMed ID: 34116295 [TBL] [Abstract][Full Text] [Related]
18. COVID-19 Vaccination-Related Uptake on FDG PET/CT: An Emerging Dilemma and Suggestions for Management. McIntosh LJ; Bankier AA; Vijayaraghavan GR; Licho R; Rosen MP AJR Am J Roentgenol; 2021 Oct; 217(4):975-983. PubMed ID: 33646823 [TBL] [Abstract][Full Text] [Related]
19. Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination. Horvat JV; Sevilimedu V; Becker AS; Perez-Johnston R; Yeh R; Feigin KN Eur Radiol; 2022 Aug; 32(8):5752-5758. PubMed ID: 35247087 [TBL] [Abstract][Full Text] [Related]